Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Chia Tai Tianqing Pharmaceutical
Chia Tai Tianqing Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Fosaprepitant dimeglumine
Fosaprepitant dimeglumine
2021-03-03
—
Fulvestrant
Fulvestrant
2020-02-07
2034
Breast neoplasms
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Fulvestrant
breast neoplasms
,
neoplasms
,
triple negative breast neoplasms
Eribulin
breast neoplasms
,
neoplasms
Eribulin mesylate
breast neoplasms
,
neoplasms
Sacituzumab
neoplasms
Mycophenolate sodium
immunosuppression therapy
,
healthy volunteers/patients
,
microscopic polyangiitis
,
congenital abnormalities
,
chronic kidney failure
,
systemic scleroderma
,
myelodysplastic syndromes
,
preleukemia
,
syndrome
,
hypoglycemia
,
lung diseases
,
interstitial lung diseases
,
localized scleroderma
,
diffuse scleroderma
,
hypertension
,
iga glomerulonephritis
,
renal hypertension
,
diabetes mellitus
,
bullous pemphigoid
,
psoriasis
,
lupus nephritis
,
nephritis
,
systemic lupus erythematosus
,
type 1 diabetes mellitus
,
neuromyelitis optica
,
pemphigus
,
myasthenia gravis
,
diabetic nephropathies
,
multiple sclerosis
,
cardiovascular diseases
,
lung transplantation
,
sarcoidosis
,
pulmonary sarcoidosis
,
membranous glomerulonephritis
,
kidney transplantation
,
liver transplantation
,
heart transplantation
,
kidney diseases
,
renal insufficiency
,
polyomavirus infections
,
corneal transplantation
,
liver diseases
,
hiv infections
,
graft vs host disease
,
hematopoietic stem cell transplantation
Benzimidazole
therapeutic equivalency
,
covid-19
,
infections
,
communicable diseases
,
chronic pain
,
alzheimer disease
,
metabolism
,
juvenile arthritis
,
arthritis
,
pancreatitis
,
chronic pancreatitis
,
pharmacokinetics
,
exercise-induced asthma
,
hematologic neoplasms
,
asthma
,
waldenstrom macroglobulinemia
,
ulcer
,
gastrointestinal diseases
,
duodenal ulcer
,
peptic ulcer
,
mantle-cell lymphoma
,
hemorrhage
,
peptic ulcer hemorrhage
,
rheumatoid arthritis
,
osteoarthritis
,
low back pain
,
digestive system diseases
,
digestive signs and symptoms
,
simian acquired immunodeficiency syndrome
,
eosinophilic esophagitis
,
esophageal neoplasms
,
precancerous conditions
,
metaplasia
,
non-hodgkin lymphoma
,
hypercholesterolemia
,
hyperlipoproteinemia type ii
,
gastrointestinal hemorrhage
,
chest pain
,
gastrinoma
,
zollinger-ellison syndrome
,
syndrome
,
gastroesophageal reflux
,
peptic esophagitis
,
esophagitis
,
healthy volunteers/patients
,
stomach ulcer
,
heartburn
,
dyspepsia
,
barrett esophagus
,
non-erosive reflux disease
,
laryngopharyngeal reflux
,
laryngitis
,
abdominal pain
,
nausea
,
gastritis
,
atrophic gastritis
,
croup
,
dyssomnias
,
parasomnias
,
bariatric surgery
,
critical illness
,
morbid obesity
,
obesity
,
pathologic constriction
,
cough
,
chronic cough
,
metabolic diseases
,
calcium metabolism disorders
,
rhinitis
,
common cold
,
vasomotor rhinitis
Sintilimab
non-small-cell lung carcinoma
,
lung neoplasms
Penpulimab
colorectal neoplasms
,
stomach neoplasms
,
squamous cell carcinoma of head and neck
,
pancreatic neoplasms
,
esophageal squamous cell carcinoma
,
squamous cell carcinoma
,
large b-cell lymphoma diffuse
,
gastrointestinal neoplasms
,
thyroid neoplasms
,
breast neoplasms
,
triple negative breast neoplasms
,
recurrence
,
sarcoma
,
rectal neoplasms
,
pheochromocytoma
,
urologic neoplasms
,
digestive system neoplasms
,
gastrointestinal stromal tumors
,
neuroendocrine tumors
,
small cell lung carcinoma
,
female genital neoplasms
,
glioblastoma
,
uterine cervical neoplasms
,
neoplasms by histologic type
,
male breast neoplasms
,
essential tremor
,
head and neck neoplasms
,
neoplasm metastasis
,
syndrome
,
gastrointestinal diseases
,
digestive system diseases
,
paraganglioma
,
osteosarcoma
,
b-cell lymphoma
,
melanoma
,
esophageal neoplasms
,
adenocarcinoma
,
neoadjuvant therapy
,
immunotherapy
,
neoplasms
,
carcinoma
,
lung neoplasms
,
hepatocellular carcinoma
,
liver neoplasms
,
nasopharyngeal carcinoma
,
nasopharyngeal neoplasms
,
lymphoma
,
squamous cell neoplasms
,
hodgkin disease
,
hypersensitivity
,
non-small-cell lung carcinoma
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
small cell carcinoma
,
thyroid diseases
Lanifibranor
healthy volunteers/patients
,
pharmacokinetics
,
fatty liver
,
type 2 diabetes mellitus
,
diabetes mellitus
,
systemic scleroderma
,
diffuse scleroderma
,
sclerosis
,
non-alcoholic fatty liver disease
,
liver diseases
,
fibrosis
Gilvetmab
carcinoma
,
non-small-cell lung carcinoma
,
lung neoplasms
,
squamous cell neoplasms
Enoblituzumab
growth disorders
,
failure to thrive
Efbemalenograstim alfa
neutropenia
,
non-small-cell lung carcinoma
,
lung neoplasms
,
febrile neutropenia
,
ovarian neoplasms
,
uterine cervical neoplasms
Aglatimagene besadenovec
thyroid neoplasms
,
glioblastoma
,
glioma
,
central nervous system neoplasms
,
melanoma
,
colonic neoplasms
,
cholangiocarcinoma
,
chondrosarcoma
,
male genital neoplasms
,
castration-resistant prostatic neoplasms
,
ovarian neoplasms
,
breast neoplasms
,
adenocarcinoma
,
colorectal neoplasms
,
non-small-cell lung carcinoma
,
stomach neoplasms
,
head and neck neoplasms
,
esophageal neoplasms
,
squamous cell carcinoma of head and neck
,
squamous cell carcinoma
,
pancreatic neoplasms
,
sarcoma
,
prostatic neoplasms
,
neoplasms
,
erectile dysfunction
,
neoplasm metastasis
,
urogenital neoplasms
,
hypersensitivity
,
prostatic hyperplasia
,
hyperplasia
,
lower urinary tract symptoms
Spartalizumab
pancreatic neoplasms
Lenograstim
recurrence
,
biphenotypic leukemia acute
,
myeloid leukemia acute
,
lymphoma
,
leukemia
,
myeloid leukemia
1
2
3
4
5
6
>
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use